In Section A, contributors will receive unique doses and schedules of oral ABBV-744 pill to recognize Risk-free dosing program. Extra members will be enrolled on the discovered monotherapy dosign program. In Segment B, individuals will obtain oral ruxolitinib and ABBV-744 are going to be offered as "insert-on" therapy. In Phase https://clinicaltrialrecruitmentf70246.blogars.com/31019489/the-2-minute-rule-for-is-abbv-744-effective-for-hematologic-cancers